Introduction
Serum Response Factor (SRF) is a member of the MADS (MCM1, Agamous and De®ciens, SRF) box family of transcription factors that is an important regulator of many genes associated with cell growth and dierentiation. SRF was ®rst identi®ed based on its ability to mediate serum and growth factor activation of the c-fos proto-oncogene (reviewed in Treisman and Ammerer, 1992) . Subsequently, it was found that SRF and/or SRF binding sites (CC(A/ T) 6 GG), termed CArG boxes, regulate expression of a wide variety of serum responsive genes (Changelian et al., 1989; Chavrier et al., 1989; Christy and Nathans, 1989; Latinkic et al., 1991; Latinkic and Lau, 1994; Treisman, 1990; Tsai-Morris et al., 1988) . SRF also regulates transcription mediated by treatment of cells with neurotrophins (Sheng et al., 1988; Visvader et al., 1988) , neurotransmitters and agents that raise intracellular calcium levels (Bading et al., 1993; McDonough et al., 1997; Misra et al., 1994) , stress agents, and viral activators (Avantaggiati et al., 1993; Fujii et al., 1992 Fujii et al., , 1994 . A variety of experiments indicate that SRF is a key transcription factor controlling genes that are involved in cell cycle progression, dierentiation, and development (Arsenian et al., 1998; Croissant et al., 1996; Gauthier-Rouviere et al., 1991; Vandromme et al., 1992) . Understanding both the mechanism by which SRF mediates the activation of genes and regulation of the SRF gene itself will therefore be important for understanding these processes.
Previously, we (Misra et al., 1991; Spencer and Misra, 1996) and others (Norman et al., 1988) have demonstrated that in response to serum stimulation the SRF gene is rapidly induced at the transcriptional level in a protein synthesis independent manner. In murine ®broblasts SRF gene expression is transient. SRF message levels peak at approximately 90 ± 120 min after serum stimulation and return to nearly basal levels by 4 ± 6 h after stimulation (Misra et al., 1991) . In recent studies, we have shown that maximal responsiveness of the SRF promoter to serum and basic ®broblast growth factor (bFGF) requires two SRF binding sites located within the ®rst 63 nucleotides upstream of the start site of transcriptional initiation, a GC box, containing overlapping Sp1/Egr-1 binding sites, located at 83 nucleotides upstream of the start site, and in the case of bFGF an ETS binding sequence located 103 nucleotides upstream of the start site of initiation (Spencer et al., 1999; Spencer and Misra, 1996) .
Whole serum contains a variety of mitogenic agents. A major mitogenic component of serum is the lipid messenger lysophosphatidic acid (LPA, 1-acyl-glycerol-3-phosphate) (Ridley and Hall, 1992) . LPA has been identi®ed as the serum-borne component that is responsible for eliciting signals that rearrange cellular architecture (Ridley and Hall, 1992) . LPA can also elicit a wide variety of other biological responses, including increasing smooth muscle contraction, platelet aggregation, neurite retraction, cell proliferation, stress ®ber formation, interleukin-2 secretion, and chemotaxis in amoebae (reviewed in Moolenar, 1995) .
LPA-dependent signaling in cells occurs through heterotrimeric G-linked protein signaling pathways (Moolenar, 1995; Moolenar et al., 1992) . LPA treatment of cells has been demonstrated to activate or inhibit at least four G-protein-linked signaling pathways in cells. These include the stimulation of phospholipase C and D by G q subfamily members, inhibition of adenylate cyclase and activation of p21
Modulation of these pathways in the cell by LPA ultimately leads to alteration in cellular phenotype, which involves new gene expression. In the case of LPA dependent activation of the c-fos proto-oncogene it has been demonstrated that members of the Rho family of GTP-binding proteins Rac1 and RhoA target the CArG box portion of the c-fos SRE to regulate transcription (Hill et al., 1995) , suggesting that SRF is required to mediate LPA-activated expression. Dominant inhibitory RasN17 also blocks LPA-inducible expression of the c-fos gene in reporter assays suggesting that Ras-dependent signaling pathways are also activated by LPA and that they target the CArG box portion of the c-fos SRE for regulation. This type of Ras-dependent activation of c-fos expression via the CArG box is distinct from Ras-dependent signals that regulate c-fos expression through a p62 TCF -dependent mechanism (Hill et al., 1995; Hipskind et al., 1994; Janknecht et al., 1993) .
In the present study, we address the role of three distinct upstream SRF promoter regulatory elements, an ETS binding site, the proximal GC box, and the CArG boxes, in mediating activation by LPA and serum. Our analysis indicates that in murine ®broblasts LPA and whole serum regulate the SRF promoter in a similar manner. Regulation occurs through a complex mechanism in which multiple Ras-related signaling pathways target distinct cis acting regulatory elements. Maximal serum-and LPA-mediated activation of the SRF gene occurs by a CArG box-dependent pathway that requires both the Sp1 binding portion of the GC box and the CArG boxes. Furthermore, our results indicate that CArG/GC box mediated activation is targeted by two dierent Ras signaling pathways. The CArG box-dependent component of this mechanism is targeted by Rho pathway dependent signals and the Sp1-dependent mechanism is regulated by a p21 Ras -dependent signaling pathway.
Results

LPA induces expression of the endogenous SRF gene
Previously, we have shown that stimulation of quiescent mouse ®broblasts with serum induces expression of the endogenous SRF gene (Misra et al., 1991) . To determine whether LPA activates SRF gene expression, a Northern blot analysis of SRF message levels was performed on RNA isolated from NIH3T3 cells before and after LPA treatment. NIH3T3 ®broblasts were grown to roughly 70% con¯uence and serum-starved for 36 h. LPA was added to 10 mM ®nal concentration, total RNA was isolated at various times after stimulation, and a Northern blot analysis was performed. As shown in Figure 1 , in response to LPA treatment of serum-starved ®broblasts, expression of the endogenous SRF gene is upregulated. An increase in SRF message accumulation is detectable within 30 min. Maximal message accumulation (eightfold) occurs between 60 ± 120 min after stimulation, and begins to decline by 180 min after stimulation. The time course of SRF message accumulation mimics that of SRF message accumulation seen after serum-starved ®broblasts are stimulated with 20% fetal bovine serum (Misra et al., 1991) , or bFGF (Spencer et al., 1999) .
GAPDH message levels remain constant over the time course of LPA stimulation indicating that increases in RNA accumulation are not due to a non-speci®c stimulation of transcription.
LPA-and serum-inducible SRF gene expression are regulated by the same cis-acting regulatory elements Three major upstream promoter regulatory elements in the SRF gene are important for serum growth factor mediated activation of the SRF promoter (Spencer et al., 1999; Spencer and Misra, 1996) . These sequences are depicted in Figure 2a (and Spencer and Misra, 1996) . They include two SRF binding sites, termed CArG boxes, located at 743 and 763, a consensus ETS binding site at 7103, and a GC box which contains an overlapping SP1/Egr-1 binding site at 783 nt, upstream of the start site of transcription. To analyse more carefully the role of these dierent SRF promoter elements in mediating LPA responsiveness, and to determine if LPA mediates SRF gene activation by a mechanism similar to that observed for serum or puri®ed growth factors, we used a sensitive RNase protection assay to measure SRF promoter activity in response to either LPA or serum stimulation. Initially, we were interested in developing an assay in which the SRF promoter controlled expression of a reporter gene containing genomic SRF transcribed sequences. This approach proved problematic and we were unable to develop a reliable protection assay from this type of a reporter, presumably due to the high G-C content of the SRF gene coding sequences (Belaguli et al., 1997; Norman et al., 1988; Spencer and Misra, 1996) . Expression of the human c-fos gene has been extensively studied by RNase protection analysis (Treisman, 1985) . We therefore decided to study the SRF promoter using the human c-fos gene as a reporter. To do this a series of chimeric SRF/c-fos reporters, based on the parent chimera depicted in Figure 2a , was constructed in which various SRF promoter mutants were fused to nearly the entire Figure 1 The SRF gene is transiently expressed in LPA treated ®broblasts. Serum-starved NIH3T3 ®broblasts were stimulated by the addition of LPA to 10 mM ®nal concentration and total RNA was isolated at various time points. Northern blot analysis was then performed using a DNA probe speci®c to the C-terminal portion of the SRF protein. To normalize for loading, the blot was re-probed with a labeled GAPDH probe. The position of the 4.5 and 2.9 kb SRF mRNAs are indicated transcribed portion of the human c-fos gene. To determine whether these chimeric reporters would respond similarly to a SRF promoter driven luciferase reporter system that was studied previously (Spencer and Misra, 1996) , we analysed the ability of chimeric reporters containing the SRF promoter to respond to serum.
Initially, the ability of a 322 nt fragment of the SRF promoter to respond to serum was determined. This fragment of the promoter has previously been shown by us to contain all the upstream sequences necessary for proper serum mediated regulation of the SRF gene using a luciferase reporter assay (Spencer and Misra, 1996) . As seen in Figure 2b in the leftmost two lanes, the SRF/c-fos reporter construct responds robustly to serum stimulation. A time course analysis of serum stimulated expression of the 7322SRF/c-fos construct revealed that in unstimulated cells the reporter message is virtually undetectable, but that by 30 min after serum stimulation message levels peak, returning to basal levels by 120 ± 240 min after stimulation (Spencer et al., 1999) . Maximal accumulation of message from the chimeric construct occurred signi®cantly earlier than maximal accumulation of message from the endogenous SRF gene (Misra et al., 1991) , and more closely parallels accumulation of message from the endogenous c-fos gene. The transient and robust nature of stimulation from the SRF/c-fos reporters suggested that this system would allow us to very sensitively measure activity of the SRF promoter.
Using the SRF promoter/c-fos reporter system we ®rst decided to more carefully analyse the contribution of the 783 GC box to serum stimulated activation. This element contains a consensus overlapping Sp1/ Egr-1 binding site, and we have previously demonstrated by electrophoretic mobility shift assays that this element can bind both factors, although binding appears to be mutually exclusive (Spencer et al., 1999) . Earlier studies using a luciferase reporter system (Spencer and Misra, 1996) implicated this region as being important for contributing to the SRF promoter serum response, however those studies failed to distinguish whether the Sp1 binding motif, the Egr-1 binding motif, or both were signi®cant for the serum response. To address which motif was important for responsiveness we tested various mutants of the 783 G-C box (Spencer et al., 1999) , depicted in Figure  2b . As shown in Figure 2b , the 783 box mutant which disrupts binding to both Sp1 and Egr-1 signi®cantly reduced serum mediated activation by approximately 50%. This eect is mediated by the Sp1 binding portion of the 783 box since a mutation that abolishes Sp1 binding, but leaves Egr-1 binding intact (mEgr-1) behaves similarly, and a mutation that abolishes Egr-1 binding, but leaves Sp1 binding intact (mSp1) has no eect on serum responsiveness. In the experiment shown in Figure 2b , and in the other protection assays in this study, the level of SRF/c-fos H message was normalized to account for both transfection eciency, using an a-globin transfection eciency control construct; and for stimulation of the cells, using the endogenous c-fos message. Our previous studies showed that the SRF binding sites, located at 763 and 743 upstream of the initiation site, were critical for mediating serum responsiveness (Spencer and Misra, 1996) . The results shown here support the ®broblasts were transfected with a 7322SRF/c-fos reporter containing the wild-type sequence (7322 WT) or mutations of the 783 binding site (previously described and characterized in (Spencer et al., 1999) that disrupted either both Sp1 and Egr-1 binding (mSp1/mEgr-1), Sp1 binding alone (mSp1), or Egr-1 binding alone (mEgr-1). Cells were serum-starved for 36 h and serum-stimulated for 30 min. RNA was isolated and RNase protection assays performed. Data were quantitated by PhosphorImager analysis and normalized for transfection eciency using an a-globin internal standard as previously described (Spencer et al., 1999) . Activation levels of the dierent mutants were determined by comparing the serum-starved level of RNA with the serum-stimulated levels and expressed as a percentage of wild-type. The c-fos H message was normalized for both transfection eciency using the a-globin reference plasmid, and for the level of cell stimulation by comparing the level of stimulation of the endogenous c-fos M message between experiments. The percentages were determined from the averages of ®ve independent experiments. Mutations used are described in experimental procedures. The positions of the protected RNA species are indicated (transfected c-fos H =251 nt., globin=133 nt., endogenous c-fos M =65 nt.) conclusion that maximal serum responsiveness requires both intact SRF and Sp1 binding sites.
We next investigated the mechanism by which LPA mediates SRF promoter activation. Previous work by Treisman and co-workers has determined that the c-fos SRE, which contains a CArG box, is capable of mediating an LPA-response (Hill et al., 1995) . To determine if the CArG boxes in the SRF gene promoter are sucient for LPA-mediated stimulation, NIH3T3 ®broblasts were transfected with a 7322SRF/c-fos or a CArG-minimal-67SRF/c-fos construct that contains only the two SRF binding sites of the SRF promoter in their natural context upstream of the SRF TATA box. These cells were serumstarved for 36 h and then stimulated with LPA. As shown in Figure 3 , the full-length SRF gene promoter (7322) is responsive to LPA (tenfold), and the response of the 767SRF/c-fos construct, while diminished, is still signi®cant (2.5-fold). A TATA only minimal SRF construct was unresponsive to LPA treatment. These results demonstrate (1) that the CArG boxes of the SRF promoter are sucient for LPA-induced SRF gene expression, and (2) that sequences in the SRF promoter are essential for LPA responsiveness. The fourfold reduction of LPA-inducible expression observed with the CArG-minimal 767SRF/c-fos reporter compared to the 7322SRF/c-fos reporter, however, suggests that other cis-acting elements in the SRF promoter cooperate with the CArG boxes to activate the SRF gene promoter.
To identify which additional cis-acting elements cooperate with SRF binding sites in mediating LPAinducible SRF gene expression, NIH3T3 ®broblasts were transfected with the 7322SRF/c-fos reporter or reporters containing in context mutations in the CArG boxes, the 783 Sp1 binding site, or the 7103 Ets binding site, as depicted in Figure 4 . Cells were then either left unstimulated or stimulated by the addition of LPA to 10 mM ®nal concentration for 30 min. RNA was isolated and RNase protection analyses were performed. As seen in Figure 4 , mutations in both CArG boxes diminish LPA responsiveness by greater than 90% compared to a wild-type promoter. Together with the results from Figure 3 , this suggests that the CArG boxes are both sucient and necessary for LPAmediated expression of the SRF gene. Figure 4 also shows that the Sp1 binding site contributes signi®cantly to the LPA response, while the 7103 ETS binding site is not important. As seen in Figure 4 , mutation of the Sp1 portion of the 783 GC box reduced LPA-mediated expression by roughly 50%, similar to what is seen in the case of the serum response. In contrast to the CArG box and Sp1 site mutations, mutation of the ETS 7103 site had no signi®cant eect on LPA-mediated SRF gene expression, or on serum-mediated expression (data not shown). Taken together, the data in Figures 2,3 and 4, and previous work (Spencer and Misra, 1996) demonstrate that the same cis-acting elements governing serum-inducible expression also regulate LPAinducible expression of the SRF gene promoter in NIH3T3 ®broblasts. Speci®cally, the CArG boxes are The CArG boxes and the 783 GC box are required for maximal reporter activity in response to LPA stimulation. NIH3T3 ®broblasts were transfected with a 7322SRF/c-fos reporter containing the wild-type sequence or mutations of the CArG box, Sp1 or ETS sequences. The mutant sequences are indicated by the ®lled-in boxes. Cells were serum-starved for 36 h and stimulated for 30 min by the addition of LPA to 10 mM ®nal concentration. RNA was isolated and RNase protection assays performed. Data were quantitated by PhosphorImager analysis and normalized for transfection eciency and cell stimulation. The c-fos H message was normalized for transfection eciency using an a-globin reference plasmid, and for the level of cell stimulation by comparing the level of stimulation of the endogenous c-fos M message between experiments. Activation of the wild-type reporter was determined by comparing the level of reporter RNA from unstimulated and stimulated cells. This value was set to 100%. Per cent activation of mutant reporters was determined by similar means and expressed as a percentage of the wild-type reporter. The percentages given are derived from ®ve independent experiments. The basal or serum-starved level of expression between constructs diered by less than 30% both necessary and sucient for both LPA-and serum-inducible expression, but maximal activation requires the participation of the SP1 binding motif of the 783 GC box.
Sp1 can potentiate both serum-and LPA-mediated SRF gene expression
The observation that the SRF binding sites and the Sp1 binding motif of the 783 GC box are required for maximal serum-and LPA-inducible expression of the SRF gene, suggest that Sp1 or a related family member participates in regulating serum-and LPA-inducible SRF gene expression. To address this possibility directly, NIH3T3 ®broblasts were transfected with a Gal4 ± SRF promoter luciferase reporter in conjunction with a plasmid expressing a Gal4 ± Sp1 fusion protein. The Gal4 ± SRF promoter luciferase reporter construct consisted of 87 nt of SRF promoter upstream from the start site of transcriptional initiation in which a single Gal4 binding site replaced the 783 GC box upstream of the SRF CArG boxes. If Sp1 can function as a component of the regulatory mechanisms governing SRF expression, the presence of Gal4 ± Sp1 should enhance serum-and LPA-responsiveness of the reporter. As shown in Figures 5a,b , addition of Gal4 ± Sp1 reproducibly enhances both serum-and LPA-inducible CArG box-dependent expression of the SRF by approximately twofold. Note that in both Figures 5a,b the reporters can still be stimulated in the absence of Gal4 ± Sp1, consistent with Figures 2b and 4, but that this activation is potentiated in the presence of Gal4 ± Sp1. The stimulation observed here is not likely to be a general eect on transcription, since Gal4 ± Sp1 does not enhance SRF promoter activity in the absence of stimulation. This enhancement is consistent with the roughly 50% loss of stimulation seen when the Sp1 site is mutated in the context of the intact promoter (Figure 2b ). These results suggest that both serum-and LPA-inducible expression of the SRF gene are controlled by analogous mechanisms involving the cooperation of Sp1 or a related factor, with SRF.
RAS family GTPases regulate serum-and LPA-mediated activation of the SRF promoter
To begin to determine whether the signaling pathways that mediate serum and LPA dependent activation of the SRF promoter were similar, we investigated the role of Ras family members in serum-and LPA-mediated signaling. To determine if Figure 5 Sp1 can potentiate both serum and LPA stimulation of the SRF promoter. NIH3T3 ®broblasts were transfected with a luciferase reporter containing a Gal4 binding site centered 20 nucleotides upstream of the two CArG boxes of the SRF gene promoter. Where indicated, a plasmid expressing a Gal4 ± Sp1 fusion protein was included. Cells were starved for 36 h and either (a) serum-or (b) LPA-stimulated for 2 h and luciferase assays performed. Fold induction was determined by comparing the serum-starved level of expression with the serum-stimulated level of expression. The level of expression of the reporter in the absence of Gal4 ± Sp1 was set to a value of 1.0. For each point, assays were determined in triplicate and corrected for transfection eciency. Results from at least three independent experiments are shown. The expression of the Gal4 DNA binding domain alone did not enhance serum-or LPA-stimulated expression (not shown). The position of the Gal4 DNA binding site (hatched box) relative to the CArG boxes are shown above each graph these regulatory molecules are involved in regulating SRF gene promoter activity in response to serum-or LPA-stimulation, dominant negative (DN) forms of Ras, Rac1 and RhoA that act by competitively inhibiting the interaction of the endogenous GTPbinding proteins with their respective GEFs were utilized (Coso et al., 1995) . NIH3T3 ®broblasts were transfected with wild-type 7322SRF/c-fos or the appropriate mutants, together with plasmids expressing dominant negative forms of Ras, Rac1 and RhoA. Cells were serum-starved for 36 h and stimulated as previously described with serum or LPA. As shown in Figure 6a ,b, DN-Ras, DN-Rac1, and DN-RhoA similarly diminish the response of the SRF promoter to serum and LPA, consistent with the hypothesis that LPA and serum regulate the SRF promoter by similar signaling pathways.
Ras superfamily members regulate serum mediated SRF promoter activity by dierent mechanisms
The results from Figure 6 indicate that signaling by Ras superfamily members is important for regulating SRF promoter activity. To investigate further the mechanism by which dierent Ras family members regulate the SRF promoter we investigated whether the 783 Sp1 and SRF binding sites were differentially regulated by Ras, Rac1 or RhoA. To determine which signaling pathway targeted the 783 Sp1 binding site, the eect of DN ± Ras, DN ± Rac1 and DN ± RhoA were tested on serum-inducible expression of 7322SRF/c-fos wild-type and mSp1783/c-fos reporters. As seen in the right hand portion of Figure  7a , consistent with Figure 2b , mutation of the 783 Sp1 site reduced serum-inducible expression by roughly 50%, relative to the wild-type construct (compare 1 and 5). The inclusion of DN ± Ras reduced the level of activated expression from the 7322SRF/c-fos wild-type reporter to a level comparable to that of the mSp1783/c-fos reporter (compare 2 and 5). In contrast, the level of serum-inducible expression of the mSp1783/c-fos reporter is not signi®cantly reduced by the inclusion of DN ± Ras (compare 5 and 6). In contrast, DN ± Rac1 and DN ± RhoA are able to exert their inhibitory eects despite the lack of a functional Sp1 binding site at 783 (compare 1 to 3 and 4, and compare 5 to 7 and 8). Similar results were obtained using LPA as the stimulatory agent (LPA data not shown). These data show that the loss of Sp1 binding correlates with the loss of DN ± Ras sensitivity. This indicates that the Sp1 site is required for regulation of the SRF promoter by Ras-dependent signaling events and that the target of Rac-and RhoA-dependent signaling events is not the Sp1 site but a dierent site in the SRF promoter.
Previously, it has been shown that Rac1-and RhoAdependent signaling events target the c-fos SRE CArG box (Fromm et al., 1997; Hill et al., 1995) . This suggests that the SRF binding sites in the SRF promoter may also be targeted by Rac1-and RhoA-dependent signaling events. To determine if the dominant inhibitory eects of Figure 6 Ras-related signaling pathways mediate serum-and LPA-stimulated activation of the SRF promoter. NIH3T3 ®broblasts were transfected with the 7322SRF/c-fos reporter. Where indicated dominant negative (DN) forms of Ras, Rac1, or RhoA were included in the transfection. Cells were serum-starved for 36 h and stimulated with either serum (a) or LPA (b). RNA was harvested and RNase protections were performed. Data were quantitated by PhosphorImager analysis and normalized for transfection eciency and cell stimulation. The c-fos H message was normalized for transfection eciency using an a-globin reference plasmid, and for the level of cell stimulation by comparing the level of stimulation of the endogenous c-fos M message between experiments. Due to the inhibitory eects of DN-Ras on the expression of the internal transfection eciency control, data was normalized between sets of lanes. The fold activation of the 7322SRF/c-fos reporter was set to 100% for each condition. Activation was determined by comparing the RNA expressed in the unstimulated and stimulated cells. The level of basal expression in each set of experiments diered by less than 27% (a) 20% FBS, four independent determinations, (b) 10 mM LPA, 3 independent determinations Rac1 and RhoA are due to targeting of the SRF binding site, we investigated whether DN ± Rac1 and DN ± RhoA could inhibit activation of the SRF gene that was dependent on the SRF binding sites. NIH3T3 ®broblasts were co-transfected with a 767 minimal SRF reporter (767SRF/c-fos and either DN ± Rac1 or DN ± RhoA and serum-starved for 36 h. Cells were stimulated with 20% fetal bovine serum for 30 min and RNase protection assays were performed. As shown in Figure 7b , DN ± Rac1 and DN ± RhoA are both able to inhibit serum-inducible expression of the CArG-minimal reporter which indicate that the CArG boxes of the SRF promoter are targets of Rac1-and RhoA-dependent signaling events.
The results of these studies are schematically depicted in Figure 8 . These data show that Ras-dependent signaling events, but not Rac1-or RhoA-dependent signaling events, require the Sp1 binding site of the 783 GC box for regulation of SRF gene expression and that Rac1-and RhoA-dependent signaling events target the SRF binding site found in the SRF promoter.
Discussion
In the present study we have examined the mechanism by which serum and LPA regulate expression of the SRF gene. Our results indicate that maximal activation is mediated by two promoter regulatory elements, an Sp1 factor binding site located at 783 and two CArG boxes located at 743 and 763 nt upstream of the start site of Figure 7 Ras signaling pathways target dierent SRF promoter elements. NIH3T3 ®broblasts were transfected with (a) the 7322SRF/c-fos reporter or mSp1783/c-fos, or (b) a 767 CArG reporter. Where indicated dominant negative (DN-) forms of Ras, Rac1, or RhoA were included in the transfection. The ®lled in box in (a) represents a mutant Sp1 binding site. Cells were serumstarved for 36 h and serum-stimulated for 30 min. RNA was harvested and RNase protections were performed. Data were quantitated by PhosphorImager analysis and normalized for transfection eciency and cell stimulation. The c-fos H message was normalized for transfection eciency using an a-globin reference plasmid, and for the level of cell stimulation by comparing the level of stimulation of the endogenous c-fos M message between experiments. Due to the repressive eects of DN-Ras on the expression of the internal transfection eciency control, data was normalized between sets of lanes and not throughout. The fold activation of the 7322SRF/c-fos reporter was set to 100%. Per cent activation was determined by comparing the fold activation of the reporters in the unstimulated and stimulated cells. The level of basal expression between experiments diered by less than 11%. The results represent the average of three independent experiments. The numbers under each vertical bar are for reference in the text Figure 8 Schematic representation of the serum-and LPAmediated mechanism of transcriptional activation of the SRF promoter suggested by the work described here. For discussion see text transcriptional initiation. The CArG boxes are both necessary and sucient for activation by serum or LPA treatment. The Sp1 binding site is insucient to mediate serum or LPA dependent activation, but it is important for potentiating the response. As summarized in Figure 8 , our results also indicate that distinct signaling pathways target these elements to mediate activation. Using dominant inhibitory versions of Ras, RhoA, and Rac1 we have demonstrated that upon stimulation by serum, the CArG boxes are targeted by Rho dependent pathways and the 783 Sp1 binding site is targeted by a Ras dependent pathway.
Recently, we have de®ned the signaling mechanism by which the SRF gene is activated by puri®ed bFGF (Spencer et al., 1999) . The results presented here indicate that LPA and serum signal to the SRF promoter by a mechanism that has similarities to, yet is distinct from, the signaling mechanism used by bFGF to activate SRF expression. In the case of bFGF, maximal stimulation of the SRF promoter requires both CArG-dependent and CArG-independent mechanisms. The CArG-dependent bFGF-mediated mechanism exhibited functional cooperation between the Sp1 and CArG binding sites. The Ras signaling pathways target the Sp1 site and Rac and Rho pathways targeted the CArG boxes, similar to the LPA and serum pathway de®ned here. However, in a CArG-independent manner, bFGF also targets the 7103 ETS consensus binding site. The signaling pathway and protein(s) that target the SRF promoter 7103 ETS site have not been de®nitively identi®ed. Maximal activation of SRF promoter by bFGF, however, requires all cis acting three elements.
What transcription factors are required for mediating serum and LPA stimulated activation of the SRF promoter? We have previously shown that SRF is a major factor that binds to the CArG boxes in the SRF promoter, and that at least one intact CArG box is sucient to mediate serum induction although both CArG boxes are required for maximal induction (Spencer and Misra, 1996) . The analysis here indicates that Sp1, or related factors, are also critical for mediating activation. The SRF promoter 783 GC box contains consensus overlapping binding sites for Sp1 and Egr-1. This overlapping motif is seen in a number of promoters suggesting that it has a conserved function (Khachigian et al., 1995) . In the SRF promoter, both these sites are capable of binding their cognate binding factors in vitro (Spencer et al., 1999) , however, only the Sp1 binding motif appears to be important for potentiating activation. As shown in Figure 2 , reporters in which the Egr-1 binding portion of the 783 GC box is speci®cally mutated, leaving the Sp1 binding site intact, show no eect on activation. In contrast, in reporters in which the Sp1 binding site is disrupted, leaving the Egr-1 binding site intact, the response is diminished. Consistent with a role for Sp1 or related factors a Gal4 targeted Sp1 can rescue a 783 GC box mutant in which the overlapping Sp1/ Egr-1 binding site is replaced with a Gal4 binding site ( Figure 5 ).
Our results also clearly point to a role for Sp1, or related factors, in mediating activation of the SRF gene by serum and LPA through a Ras dependent mechanism. How this Sp1 factor-dependent mechanism is operating, however, is unclear. One possibility is that Ras activated kinases target Sp1 or other Sp factors. However, while viral Ras oncogenes can activate promoters in an Sp1-dependent manner (Chen et al., 1997) to our knowledge there are no reports of Ras dependent inducible phosphorylation or activation of Sp1 factors. Although, recently in rat ventricular myocytes Sp1 has been found to be involved in calcium-mediated atrial natriuretic factor gene expression in response to pacing (McDonough et al., 1997) , and it was suggested that this may occur through a JNK-dependent pathway. Our observation that the 783 GC box is unable to mediate activation of the SRF promoter in the absence of an intact CArG box suggests that direct targeting of Sp1 is not sucient, and may not be necessary to activate transcription. One possibility is that Sp1 or related factors may be permissive for a complex which consists of at least SRF and Sp1. In this scenario Ras-dependent signaling may directly target either SRF or another, yet to be identi®ed, member of this complex. Consistent with this idea, it has previously been shown that SRF is a target for Ras/MAPK regulated RSK family members, and that it can be inducibly phosphorylated on Ser-103 (Rivera et al., 1993) . The role of Ser-103 has been examined in the context of mitogen mediated activation of the c-fos proto-oncogene (Hill et al., 1994) . While there is no evidence that Ser-103 phosphorylation is required in that context, it may be possible that in a dierent promoter architecture, such as that found in the SRF gene promoter, that Ser-103 may be important. Another recent interesting report has shown that Ras regulates association of SRF with C/EBP-b to stimulate transcription (Hanlon and Sealy, 1999) . Although, the role of Sp1 in this mechanism was not addressed in this report, it is interesting to speculate that Sp1 may promote an SRF ± C/EBP-b complex.
Materials and methods
Construction of SRF chimeric reporter plasmids and mutagenesis
The SRF/c-fos chimeric reporter 7322SRF/c-fos and the various promoter mutants were created by replacing the c-fos promoter in plasmid pF4 (human c-fos genomic clone (Treisman, 1985) ) with 322 nucleotides of the wild-type SRF gene promoter, or mutants, as previously described (Spencer et al., 1999) . The SRE minimal promoter 763SRF/ c-fos chimeric reporter was generated by PCR. Primer sequences used were 5'-CCGATCTCCCATA-TAAGGGCG-3' and 5'-ATAAGAATGCGGCCGCGAGGGGCCGG-GAC-3'. Primer sequences used to generate point mutations of the proximal GC box that distinguished between Sp1 and Egr-1 binding were as follows: mSp1-5'-GCCCCC-CTTTATGTCG-3', which disrupts the Sp1 site, and mEgr-1-5'-CGAGCCCCCAGTTTCCCCGCCCC-3', which disrupts the Egr-1 binding site. A mutation which disrupts both Sp1 and Egr-1 binding (mSp1/mEgr-1) to the proximal GC box has been previously described (Spencer and Misra, 1996) . The binding ability of mutant transcription factor binding sites was determined by gel mobility shift assays using NIH3T3 nuclear extracts, puri®ed proteins, and in vitro translated proteins, and representative experiments are shown in (Spencer and Misra, 1996) and (Spencer et al., 1999) .
Cell culture and transfections, RNase protections and luciferase assays NIH3T3 ®broblasts were cultured and transfected with reporter constructs and DN-inhibitory GTPase constructs as previously described (Spencer et al., 1999; Spencer and Misra, 1996) . The dominant inhibitory constructs used were: pRSV ± RasN17 (Hill et al., 1995) , pCEV29 RhoAN19 (Coso et al., 1995) , and pCEV29 Rac1N19 (Coso et al., 1995) . The Rac and Rho constructs have been previously described and their expression characterized (Coso et al., 1995) . Twelve to 16 h after transfection, cells were washed with warm PBS and then placed for 24 ± 36 h in starvation media containing 0.5% calf serum supplemented DMEM. Cells were stimulated with either 20% FBS supplemented DMEM (HyClone), or 10 mM lysophosphatidic acid (LPA) (Sigma) for 30 min unless otherwise noted. Total RNA was isolated by the RNeasy mini kit protocol (Qiagen) or Trizol reagent (Gibco) as directed by the manufacturer and subsequently DNAse treated for 30 min at 378C. Synthesis of 32 P riboprobes, hybridization, RNase treatment and electrophoresis were performed as described (Spencer and Misra, 1996) . The human c-fos probe protects a fragment of 251 nucleotides from the transfected SRF/c-fos reporters and a 65 nucleotide fragment from the endogenous murine c-fos RNA. The aglobin probe protects a fragment of 133 nucleotides. Data was quantitated using a Molecular Dynamics PhosphorImager. The Gal4-Sp1 expression construct, containing the fulllength Sp1 fused to a Gal4 DNA binding site, was a gift of Robert Tjian. Luciferase assays were performed as described by Promega. Luciferase activity was measured as previously described (Spencer and Misra, 1996) .
Northern blot analysis
Total cellular RNA was isolated as above and Northern analysis carried out as described (Spencer et al., 1999) .
